乌帕替尼半水合物
Upadacitinib hemihydrate
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Upadacitinib hemihydrate
CAS2050057-56-0
FormulaC34H40F6N12O3
MW778.75
Security information
Product details

Upadacitinib, also known as ABT-494, is a potent and selective JAK inhibitors in development for rheumatoid arthritis. ABT-494 is approximately 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. ABT-494 demonstrates efficacy in rat arthritis models. Preliminary evidence suggests that compared to tofacitinib, ABT-494 may spare Jak2 and Jak3 dependent signaling.

Related literature
Related
Sorry, no related items
History
AOH1996 | N-[2-[2-(3-methoxyphenoxy)anilino]-2-oxoethyl]naphthalene-1-carboxamide
Abarelix Acetate (Synonyms: PPI 149 Acetate; R 3827 Acetate)
Chloroquine (Synonyms: NSC-187208; CHQ; CQ)
Fluticasone Furoate (Synonyms: GW685698)
Dydrogesterone EP Impurity A;(9ß,10a)-Pregna-4,6,8(14)-triene-3,20-dione, 9ß,10a-Pregna-4,6,8(14)-triene-3,20-dione, Dydrogesterone Imp. A (EP)
Upadacitinib hemihydrate
Rosiglitazone HCl | BRL 49653 hydrochloride
Deucravacitinib (Synonyms: BMS-986165)
GW 501516 (Synonyms: GW 1516; GSK-516; GW-501516; Cardarine)
SKLB4771 | FLT3-IN-1